Superstring Capital Management LP Cytokinetics Inc Transaction History
Superstring Capital Management LP
- $115 Billion
- Q4 2024
A detailed history of Superstring Capital Management LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Superstring Capital Management LP holds 129,389 shares of CYTK stock, worth $6.5 Million. This represents 5.27% of its overall portfolio holdings.
Number of Shares
129,389
Previous 215,798
40.04%
Holding current value
$6.5 Million
Previous $11.4 Billion
46.58%
% of portfolio
5.27%
Previous 9.97%
Shares
5 transactions
Others Institutions Holding CYTK
# of Institutions
396Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$737 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$599 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$540 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$396 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$310 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.73B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...